Compounds > 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid

5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid and 6-(4-bromophenyl)-2-methyl-3-pyridinecarboxylic acid

5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid has been researched along with 6-(4-bromophenyl)-2-methyl-3-pyridinecarboxylic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bednar, B; Cunningham, ME; Kapitskaya, M; Kornienko, O; Lacson, R; Petrukhin, K1

Other Studies

1 other study(ies) available for 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid and 6-(4-bromophenyl)-2-methyl-3-pyridinecarboxylic acid

ArticleYear
Development of the high throughput screening assay for identification of agonists of an orphan nuclear receptor.
    Assay and drug development technologies, 2006, Volume: 4, Issue:3

    Topics: Animals; Biological Assay; CHO Cells; Cricetinae; Cricetulus; Drug Design; Flow Cytometry; Orphan Nuclear Receptors; Pharmaceutical Preparations; Protein Interaction Mapping; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2006